U.S. House · 119th Congress · H.R. 8339

Drug Origin Transparency Act of 2026

To amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting, and for other purposes.

Log in to follow this bill and get an email when there’s a new vote (premium).

Sponsor: Doris O. MatsuiD-CA-7
Introduced: April 16, 2026, in the House
Issue areas: Healthcare
Policy area: Health (from the Congressional Research Service)
Full text and actions: congress.gov

Votes on this bill (0)

Neither the House nor the Senate has held a roll-call vote on this bill.

Cosponsors (3)

2 Republicans, 1 Democrat. Each member is shown with the party they were counted with on the day they signed on. How we count these

Original cosponsors